Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Submitted by
admin
on May 5, 2012 - 4:38pm
Source:
Pharmabiz
News Tags:
Pfizer
Quark Pharmaceuticals
Silence Therapeutics
PF-655
Open-Angle Glaucoma
diabetic macular oedema
AtuRNAi
Headline:
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Do Not Allow Advertisers to Use My Personal information
